The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Open accessAbstract
The past decades have witnessed great progress in cancer immunotherapy, which has profoundly revolutionized oncology, whereas low patient response rates and potential immune‐related adverse events remain major clinical challenges. With the advantages of controlled delivery and modular flexibility, cancer nanomedicine has offered opportunities to strengthen antitumor immune responses and to sensitize tumor to immunotherapy. Furthermore, tumor‐microenvironment (TME)‐responsive nanomedicine has been demonstrated to achieve specific and localized amplification of the immune response in tumor tissue in a safe and effective manner, increasing patient response rates to immunotherapy and reducing the immune‐related side effects simultaneously. Here, the recent progress of TME‐responsive nanomedicine for cancer immunotherapy is summarized, which responds to the signals in the TME, such as weak acidity, reductive environment, high‐level reactive oxygen species, hypoxia, overexpressed enzymes, and high‐level adenosine triphosphate. Moreover, the potential to combine nanomedicine‐based therapy and immunotherapeutic strategies to overcome each step of the cancer‐immunity cycle and to enhance antitumor effects is discussed. Finally, existing challenges and further perspectives in this rising field with the hope for improved development of clinical applications are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
Physiological concentrations of purines and pyrimidines
Traut, T. W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00928361 · Cited by 1,867
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Chen, Q., Xu, L., Liang, C., Wang, C., Peng, R., & Liu, Z. (2016) · Nature Communications · doi:10.1038/ncomms13193 · Cited by 1,596
Yang, G., Xu, L., Chao, Y., Xu, J., Sun, X., Wu, Y., Peng, R., & Liu, Z. (2017) · Nature Communications · doi:10.1038/s41467-017-01050-0 · Cited by 1,477
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Vaddepally, R. K., Kharel, P., Pandey, R., Garje, R., & Chandra, A. B. (2020) · Cancers · doi:10.3390/cancers12030738 · Cited by 1,196
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172
ROS homeostasis and metabolism: a dangerous liason in cancer cells
Panieri, E., & Santoro, M. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.105 · Cited by 1,151
(1996) · PubMed · Cited by 1,141
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.061 · Cited by 1,004
Vaupel, P. W., Schlenger, K., Knoop, C., & Höckel, M. (1991) · PubMed · Cited by 952
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Enhancing cancer immunotherapy with nanomedicine
Irvine, D. J., & Dane, E. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0269-6 · Cited by 882
Tim‐3 and its role in regulating anti‐tumor immunity
Das, M., Zhu, C., & Kuchroo, V. K. (2017) · Immunological Reviews · doi:10.1111/imr.12520 · Cited by 856
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Strategies for advancing cancer nanomedicine
Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 812
Wang, Y., Zhou, K., Huang, G., Hensley, C., Huang, X., Ma, X., Zhao, T., Sumer, B. D., DeBerardinis, R. J., & Gao, J. (2014) · Nature Materials · doi:10.1038/nmat3819 · Cited by 773
Microenvironmental regulation of therapeutic response in cancer
Klemm, F., & Joyce, J. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.11.006 · Cited by 771
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
Liu, X., Pu, Y., Cron, K., Deng, L., Kline, J., Frazier, W. A., Xu, H., Peng, H., Fu, Y.-X., & Xu, M. M. (2015) · Nature Medicine · doi:10.1038/nm.3931 · Cited by 767
Hypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724
Enzyme-responsive polymeric assemblies, nanoparticles and hydrogels
Hu, J., Zhang, G., & Liu, S. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35103j · Cited by 722
Derailed endocytosis: an emerging feature of cancer
Mosesson, Y., Mills, G. B., & Yarden, Y. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2521 · Cited by 718
Regulation of Immunity and Inflammation by Hypoxia in Immunological Niches
Taylor, C. T., & Colgan, S. P. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.103 · Cited by 713
Cancer immunotherapy: Pros, cons and beyond
Tan, S., Li, D., & Zhu, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109821 · Cited by 688
ATP-triggered anticancer drug delivery
Mo, R., Jiang, T., DiSanto, R., Tai, W., & Gu, Z. (2014) · Nature Communications · doi:10.1038/ncomms4364 · Cited by 682
Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges
Saravanakumar, G., Kim, J., & Kim, W. J. (2017) · Advanced Science · doi:10.1002/advs.201600124 · Cited by 675
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
Yang, M., Li, J., Gu, P., & Fan, X. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.12.010 · Cited by 670
Shae, D., Becker, K. W., Christov, P., Yun, D. S., Lytton-Jean, A. K. R., Sevimli, S., Ascano, M., Kelley, M., Johnson, D. B., Balko, J. M., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0342-5 · Cited by 668
Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Chen, Q., Chen, J., Yang, Z., Xu, J., Xu, L., Liang, C., Han, X., & Liu, Z. (2019) · Advanced Materials · doi:10.1002/adma.201802228 · Cited by 661
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Tang, L., Zheng, Y., Melo, M. B., Mabardi, L., Castaño, A. P., Xie, Y.-Q., Li, N., Kudchodkar, S. B., Wong, H. C., Jeng, E. K., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4181 · Cited by 660
Co-evolution of tumor cells and their microenvironment
Polyak, K., Haviv, I., & Campbell, I. G. (2009) · Trends in Genetics · doi:10.1016/j.tig.2008.10.012 · Cited by 628
Wang, C., Wang, J., Zhang, X., Yu, S., Wen, D., Hu, Q., Ye, Y., Bomba, H., Hu, X., Liu, Z., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan3682 · Cited by 591
Du, J., Sun, T., Song, W., Wu, J., & Wang, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907210 · Cited by 520
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Zhou, F., Feng, B., Yu, H., Wang, D., Wang, T., Ma, Y., Wang, S., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201805888 · Cited by 507
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Self-citationSize-Tunable Strategies for a Tumor Targeted Drug Delivery System
Yu, W., Liu, R., Zhou, Y., & Gao, H. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01139 · Cited by 489
Self-citationYang, Q., Guo, N., Zhou, Y., Chen, J., Wei, Q., & Han, M. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.004 · Cited by 471
Combining Nanomedicine and Immunotherapy
Shi, Y., & Lammers, T. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00148 · Cited by 457
Feng, B., Zhou, F., Hou, B., Wang, D., Wang, T., Fu, Y., Ma, Y., Yu, H., & Li, Y. (2018) · Advanced Materials · doi:10.1002/adma.201803001 · Cited by 451
Sequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors
Chen, J., Ding, J., Wang, Y., Cheng, J., Ji, S., Zhuang, X., & Chen, X. (2017) · Advanced Materials · doi:10.1002/adma.201701170 · Cited by 420
Enzyme responsive drug delivery systems in cancer treatment
Shahriari, M., Zahiri, M., Abnous, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.004 · Cited by 415
Wang, D., Wang, T., Liu, J., Yu, H., Jiao, S., Feng, B., Zhou, F., Fu, Y., Yin, Q., Zhang, P., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b01994 · Cited by 405
Yang, G., Xu, L., Xu, J., Zhang, R., Song, G., Chao, Y., Feng, L., Han, F., Dong, Z., Li, B., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00040 · Cited by 397
Liu, R., Zhang, Y., Zhao, X., Agarwal, A., Mueller, L. J., & Feng, P. (2010) · Journal of the American Chemical Society · doi:10.1021/ja907838s · Cited by 395
Development of endogenous enzyme-responsive nanomaterials for theranostics
Mu, J., Lin, J., Huang, P., & Chen, X. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00663b · Cited by 393
Development and application of hyaluronic acid in tumor targeting drug delivery
Luo, Z., Dai, Y., & Gao, H. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.004 · Cited by 379
Self-citationHypoxia-Sensitive Fluorescent Probes for in Vivo Real-Time Fluorescence Imaging of Acute Ischemia
Kiyose, K., Hanaoka, K., Oushiki, D., Nakamura, T., Kajimura, M., Suematsu, M., Nishimatsu, H., Yamane, T., Terai, T., Hirata, Y., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja105937q · Cited by 373
Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy
Deng, H., Zhou, Z., Yang, W., Lin, L.-S., Wang, S., Niu, G., Song, J., & Chen, X. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b05210 · Cited by 363
Liu, X., Chen, Y., Li, H., Huang, N., Jin, Q., Ren, K., & Ji, J. (2013) · ACS Nano · doi:10.1021/nn402201w · Cited by 356
Prodrugs for improving tumor targetability and efficiency
Mahato, R., Tai, W., & Cheng, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.002 · Cited by 353
Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody
Wang, C., Sun, W., Wright, G., Wang, A. Z., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201506312 · Cited by 344
What's wrong with our cancer models?
Kamb, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1635 · Cited by 335
Ruan, S., Yuan, M., Zhang, L., Hu, G., Chen, J., Cun, X., Zhang, Q., Yang, Y., He, Q., & Gao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.007 · Cited by 332
Self-citationNear-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy
Sun, H., Zhang, Q., Li, J., Peng, S., Wang, X., & Cai, R. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101073 · Cited by 332
Self-citationCheng, K., Ding, Y., Zhao, Y., Ye, S., Zhao, X., Zhang, Y., Ji, T., Wu, H., Wang, B., Anderson, G. J., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b01071 · Cited by 325
Yang, N., Xiao, W., Song, X., Wang, W., & Dong, X. (2020) · Nano-Micro Letters · doi:10.1007/s40820-019-0347-0 · Cited by 324
Metabolic origins of spatial organization in the tumor microenvironment
Carmona-Fontaine, C., Deforet, M., Akkari, L., Thompson, C. B., Joyce, J. A., & Xavier, J. B. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700600114 · Cited by 323
Proton-driven transformable nanovaccine for cancer immunotherapy
Gong, N., Zhang, Y., Teng, X., Wang, Y., Huo, S., Qing, G., Ni, Q., Li, X., Wang, J., Ye, X., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-00782-3 · Cited by 300
Injectable Bioresponsive Gel Depot for Enhanced Immune Checkpoint Blockade
Yu, S., Wang, C., Yu, J., Wang, J., Lu, Y., Zhang, Y., Zhang, X., Hu, Q., Sun, W., He, C., et al. (2018) · Advanced Materials · doi:10.1002/adma.201801527 · Cited by 294
Ruan, S., Cao, X., Cun, X., Hu, G., Zhou, Y., Zhang, Y., Lu, L., He, Q., & Gao, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.006 · Cited by 290
Self-citationLi, H., Qiu, Z., Li, F., & Wang, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.6924 · Cited by 290
Nanogel: A Versatile Nano-Delivery System for Biomedical Applications
Yin, Y., Hu, B., Yuan, X., Cai, L., Gao, H., & Yang, Q. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030290 · Cited by 289
Self-citationChiang, C.-S., Lin, Y.-J., Lee, R., Lai, Y.-H., Cheng, H.-W., Hsieh, C.-H., Shyu, W.-C., & Chen, S.-Y. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0146-7 · Cited by 283
Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation
Ruan, S., Hu, C., Tang, X., Cun, X., Xiao, W., Shi, K., He, Q., & Gao, H. (2016) · ACS Nano · doi:10.1021/acsnano.6b05070 · Cited by 263
Self-citationHypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Kumari, R., Sunil, D., & Ningthoujam, R. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.041 · Cited by 263
Ojha, T., Pathak, V., Shi, Y., Hennink, W. E., Moonen, C. T. W., Storm, G., Kiessling, F., & Lammers, T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.007 · Cited by 260
Cancer Immunotherapy, Part 3: Challenges and Future Trends.
Ventola, C. L. (2017) · PubMed · Cited by 257
Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
Yang, S., & Gao, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.004 · Cited by 256
Self-citationSong, Q., Yin, Y., Shang, L., Wu, T., Zhang, D., Kong, M., Zhao, Y., He, Y., Tan, S., Guo, Y., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03186 · Cited by 254
Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy
Feng, B., Hou, B., Xu, Z., Saeed, M., Yu, H., & Li, Y. (2019) · Advanced Materials · doi:10.1002/adma.201902960 · Cited by 245
Wang, H., Han, X., Dong, Z., Xu, J., Wang, J., & Liu, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902440 · Cited by 244
Sun, L., Shen, F., Tian, L., Tao, H., Xiong, Z., Xu, J., & Liu, Z. (2021) · Advanced Materials · doi:10.1002/adma.202007910 · Cited by 243
Esterase‐Activated Charge‐Reversal Polymer for Fibroblast‐Exempt Cancer Gene Therapy
Qiu, N., Liu, X., Zhong, Y., Zhou, Z., Piao, Y., Miao, L., Zhang, Q., Tang, J., Huang, L., & Shen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201603095 · Cited by 239
Designing nanomedicine for immuno-oncology
Jiang, W., von Roemeling, C. A., Chen, Y., Qie, Y., Liu, X., Chen, J., & Kim, B. Y. S. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0029 · Cited by 229
Liu, Y., Qiao, L., Zhang, S., Wan, G., Chen, B., Zhou, P., Zhang, N., & Wang, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.010 · Cited by 218
Zhou, Y., Chen, X., Cao, J., & Gao, H. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00649a · Cited by 213
Self-citationDu, J.-Z., Mao, C.-Q., Yuan, Y.-Y., Yang, X.-Z., & Wang, J. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.002 · Cited by 202
Tang, R., Ji, W., Panus, D., Palumbo, R. N., & Wang, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.12.005 · Cited by 202
Shi, C., Liu, T., Guo, Z., Zhuang, R., Zhang, X., & Chen, X. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03568 · Cited by 202
Xu, C., Nam, J., Hong, H., Xu, Y., & Moon, J. J. (2019) · ACS Nano · doi:10.1021/acsnano.9b06691 · Cited by 198
Lian, G., Gnanaprakasam, J. R., Wang, T., Wu, R., Chen, X., Liu, L., Shen, Y., Yang, M., Yang, J., Chen, Y., et al. (2018) · eLife · doi:10.7554/elife.36158 · Cited by 196
Duan, F., Feng, X., Yang, X., Sun, W., Jin, Y., Liu, H., Ge, K., Li, Z., & Zhang, J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.017 · Cited by 193
Dai, L., Li, K., Li, M., Zhao, X., Luo, Z., Lu, L., Luo, Y., & Cai, K. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201707249 · Cited by 193
Ruan, S., Zhou, Y., Jiang, X., & Gao, H. (2021) · Advanced Science · doi:10.1002/advs.202004025 · Cited by 193
Self-citationRegulation of endocytosis via the oxygen-sensing pathway
Wang, Y., Roche, O., Yan, M. S., Finak, G., Evans, A. J., Metcalf, J. L., Hast, B. E., Hanna, S. C., Wondergem, B., Furge, K. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1922 · Cited by 192
Ruan, S., Xie, R., Qin, L., Yu, M., Xiao, W., Hu, C., Yu, W., Qian, Z., Ouyang, L., He, Q., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03968 · Cited by 191
Self-citationpH-Sensitive nanoscale materials as robust drug delivery systems for cancer therapy
Shi, Z., Li, Q., & Mei, L. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.03.001 · Cited by 188
ATP‐Responsive and ATP‐Fueled Self‐Assembling Systems and Materials
Deng, J., & Walther, A. (2020) · Advanced Materials · doi:10.1002/adma.202002629 · Cited by 188
Sun, F., Zhu, Q., Li, T., Saeed, M., Xu, Z., Zhong, F., Song, R., Huai, M., Zheng, M., Xie, C., et al. (2021) · Advanced Science · doi:10.1002/advs.202002746 · Cited by 188
Shen, S., Li, H.-J., Chen, K.-G., Wang, Y.-C., Yang, X.-Z., Lian, Z.-X., Du, J.-Z., & Wang, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01193 · Cited by 186
Deng, H., Liu, J., Zhao, X., Zhang, Y., Liu, J., Xu, S., Deng, L., Dong, A., & Zhang, J. (2014) · Biomacromolecules · doi:10.1021/bm501290t · Cited by 185
Liu, D., Chen, B., Mo, Y., Wang, Z., Qi, T., Zhang, Q., & Wang, Y. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02306 · Cited by 185
Voskuil, F. J., Steinkamp, P. J., Zhao, T., van der Vegt, B., Koller, M., Doff, J. J., Jayalakshmi, Y., Hartung, J. P., Gao, J., Sumer, B. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16814-4 · Cited by 180
Bien, M., Longen, S., Wagener, N., Chwalla, I., Herrmann, J. M., & Riemer, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.017 · Cited by 179
Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival
Frezza, C., Zheng, L., Tennant, D. A., Papkovsky, D. B., Hedley, B. A., Kalna, G., Watson, D. G., & Gottlieb, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024411 · Cited by 177
Liu, R., An, Y., Jia, W., Wang, Y., Wu, Y., Zhen, Y., Cao, J., & Gao, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.043 · Cited by 175
Self-citationLi, Z., Wang, Y., Shen, Y., Qian, C., Oupicky, D., & Sun, M. (2020) · Science Advances · doi:10.1126/sciadv.aaz9240 · Cited by 171
Wang, C., Li, P., Liu, L., Pan, H., Li, H., Cai, L., & Ma, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.040 · Cited by 170
Okuda, K., Okabe, Y., Kadonosono, T., Ueno, T., Youssif, B. G. M., Kizaka-Kondoh, S., & Nagasawa, H. (2012) · Bioconjugate Chemistry · doi:10.1021/bc2004704 · Cited by 169
A nanoparticle’s pathway into tumours
de Lázaro, I., & Mooney, D. J. (2020) · Nature Materials · doi:10.1038/s41563-020-0669-9 · Cited by 167
Fisher, J., Zeitouni, N. C., Fan, W., & Samie, F. H. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.07.005 · Cited by 161
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity
Liang, J., Wang, H., Ding, W., Huang, J., Zhou, X., Wang, H., Dong, X., Li, G., Chen, E., Zhou, F., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc3646 · Cited by 159
Qin, L., Cao, J., Shao, K., Tong, F., Yang, Z., Lei, T., Wang, Y., Hu, C., Umeshappa, C. S., Gao, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb3116 · Cited by 157
Self-citationZou, J., Zhang, F., Zhang, S., Florez-Pollack, S., Elsabahy, M., Fan, J., & Wooley, K. L. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300235 · Cited by 155
Li, K., Lin, C., He, Y., Lu, L., Xu, K., Tao, B., Xia, Z., Zeng, R., Mao, Y., Luo, Z. Y., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c07071 · Cited by 155
The progress and perspective of nanoparticle-enabled tumor metastasis treatment
Zhang, W., Wang, F., Hu, C., Zhou, Y., Gao, H., & Hu, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.07.013 · Cited by 153
Self-citationTumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.
Pham, H. T., Block, N. L., & Lokeshwar, V. B. (1997) · PubMed · Cited by 150
He, Y., Lei, L., Cao, J., Yang, X., Cai, S., Tong, F., Huang, D., Mei, H., Luo, K., Gao, H., et al. (2021) · Science Advances · doi:10.1126/sciadv.aba0776 · Cited by 148
Self-citationIm, S., Lee, J., Park, D., Park, A., Kim, Y., & Kim, W. J. (2018) · ACS Nano · doi:10.1021/acsnano.8b07045 · Cited by 146
Chung, C., Lu, K.-Y., Lee, W.-C., Hsu, W., Lee, W.-F., Dai, J.-Z., Shueng, P., Lin, C., & Mi, F. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120227 · Cited by 144
The progress and perspective of strategies to improve tumor penetration of nanomedicines
Hu, J., Yuan, X., Wang, F., Gao, H., Liu, X., & Zhang, W. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.11.006 · Cited by 144
Self-citationEngineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer
Zhou, L., Hou, B., Wang, D., Sun, F. Z., Song, R., Shao, Q., Wang, H., Yu, H., & Li, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01140 · Cited by 140
Peng, J., Yang, Q., Xiao, Y., Shi, K., Liu, Q., Hao, Y., Yang, F., Han, R., & Qian, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201900004 · Cited by 139
Considerations for designing preclinical cancer immune nanomedicine studies
Jiang, W., Wang, Y., Wargo, J. A., Lang, F. F., & Kim, B. Y. S. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-00817-9 · Cited by 137
Elnakish, M. T., Hassanain, H. H., Janssen, P. M. L., Angelos, M. G., & Khan, M. (2013) · The Journal of Pathology · doi:10.1002/path.4255 · Cited by 136
Wen, Y., Chen, X., Zhu, X., Gong, Y., Yuan, G., Qin, X., & Liu, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b17137 · Cited by 134
iRGD Modified Chemo‐immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma
Kuang, J., Song, W. L., Yin, J., Zeng, X., Han, S. H., Zhao, Y., Tao, J., Liu, C., He, X., & Zhang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201800025 · Cited by 133
Yu, M., Duan, X., Cai, Y., Zhang, F., Jiang, S., Han, S., Shen, J., & Shuai, X. (2019) · Advanced Science · doi:10.1002/advs.201900037 · Cited by 127
Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy
Li, L., Yáng, Z., & Chen, X. S. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00334 · Cited by 127
Zhou, P., Qin, J., Zhou, C., Wan, G., Liu, Y., Zhang, M., Yang, X., Zhang, N., & Wang, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.007 · Cited by 125
Su, Z., Xiao, Z., Wang, Y., Huang, J., An, Y., Wang, X., & Shuai, X. (2020) · Small · doi:10.1002/smll.201906832 · Cited by 124
Bioresponsive Protein Complex of aPD1 and aCD47 Antibodies for Enhanced Immunotherapy
Chen, Q., Chen, G., Chen, J., Shen, J., Zhang, X., Wang, J., Chan, A., & Gu, Z. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00584 · Cited by 123
Peng, S., Ouyang, B., Men, Y., Du, Y., Cao, Y., Xie, R., Pang, Z., Shen, S., & Yang, W. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119680 · Cited by 123
Self-citationAdvances in aggregatable nanoparticles for tumor-targeted drug delivery
Yu, W., Shevtsov, M. A., Chen, X., & Gao, H. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.02.036 · Cited by 123
Self-citationNanomedicine-based drug delivery towards tumor biological and immunological microenvironment
Li, J., & Burgess, D. J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.008 · Cited by 123
Tumor-Targeted Nanomedicine for Immunotherapy
Cabral, H., Kinoh, H., & Kataoka, K. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00518 · Cited by 120
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Zhu, Y., Yu, X., Thamphiwatana, S., Zheng, Y., & Pang, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.010 · Cited by 118
Biodegradable Zwitterionic Nanogels with Long Circulation for Antitumor Drug Delivery
Men, Y., Peng, S., Yang, P., Jiang, Q., Zhang, Y., Shen, B., Dong, P., Pang, Z., & Yang, W. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b03943 · Cited by 115
Self-citationLiu, Y., Ding, X., Li, J., Luo, Z. Y., Hu, Y., Liu, J., Dai, L., Zhou, J., Hou, C., & Cai, K. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/14/145102 · Cited by 114
Li, Q., Zhang, D., Zhang, J., Jiang, Y., Song, A., Li, Z., & Luan, Y. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02923 · Cited by 114
Li, X., Jeon, Y., Kwon, N., Park, J.-G., Guo, T., Kim, H., Huang, J., Lee, D., & Yoon, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120430 · Cited by 112
Yang, X., Hu, C., Tong, F., Liu, R., Zhou, Y., Qin, L., Ouyang, L., & Gao, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901896 · Cited by 111
Self-citationDing, Y., Sun, Z., Gao, Y., Zhang, S., Yang, C., Qian, Z., Jin, L., Zhang, J., Zeng, C. C., Mao, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202102188 · Cited by 110
Recent progress in tumor photodynamic immunotherapy
Shen, L., Zhou, T., Fan, Y., Chang, X. Y., Wang, Y., Sun, J., Xing, L., & Jiang, H. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.02.007 · Cited by 109
An ancestral recombination graph of human, Neanderthal, and Denisovan genomes
Schaefer, N. K., Shapiro, B., & Green, R. E. (2021) · Science Advances · doi:10.1126/sciadv.abc0776 · Cited by 106
Liu, R., Yu, M., Yang, X., Umeshappa, C. S., Hu, C., Yu, W., Qin, L., Huang, Y., & Gao, H. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201808462 · Cited by 103
Self-citationHu, X., Hou, B., Xu, Z., Saeed, M., Sun, F. Z., Gao, Z., Lai, Y., Zhu, T., Zhang, F., Zhang, W., et al. (2020) · Advanced Science · doi:10.1002/advs.201903332 · Cited by 102
Qin, Y., Tong, F., Zhang, W., Zhou, Y., He, S., Xie, R., Lei, T., Wang, Y., Peng, S., Li, Z., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104645 · Cited by 102
Self-citationRecent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
Bukhari, S. I., Imam, S. S., Ahmad, M. Z., Vuddanda, P. R., Alshehri, S., Mahdi, W. A., & Ahmad, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060840 · Cited by 101
Liu, Y., Lu, Y., Zhu, X., Li, C., Yan, M., Pan, J., & Ma, G. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119933 · Cited by 100
Shi, Y. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900215 · Cited by 100
Yang, K., Yu, G., Tian, R., Zhou, Z., Deng, H., Li, L., Yáng, Z., Zhang, G., Liu, D., Wei, J., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202008078 · Cited by 97
Shape Transformable Strategies for Drug Delivery
Jia, W., Wang, Y., Liu, R., Yu, X., & Gao, H. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009765 · Cited by 97
Self-citationDu, H., Zhao, S., Wang, Y., Wang, Z., Chen, B., Yan, Y., Yin, Q., Liu, D., Wan, F., Zhang, Q., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003757 · Cited by 96
Carbon‐Dot‐Based Nanosensors for the Detection of Intracellular Redox State
Liu, Y., Tian, Y., Tian, Y., Wang, Y., & Yang, W. (2015) · Advanced Materials · doi:10.1002/adma.201503662 · Cited by 88
Xu, C., Yu, Y., Sun, Y., Kong, L., Yang, C., Hu, M. Y., Yang, T., Zhang, J., Hu, Q., & Zhang, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201905213 · Cited by 84
Silva, V. L., & Al-Jamal, W. T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.013 · Cited by 82
Dai, L., Li, X., Yao, M., Niu, P., Yuan, X., Li, K., Chen, M., Fu, Z., Duan, X., Liu, H., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119901 · Cited by 82
Self-citationJi, T., Lang, J., Ning, B., Qi, F., Wang, H., Zhang, Y., Zhao, R., Yang, X. P., Zhang, L., Li, W., et al. (2018) · Advanced Materials · doi:10.1002/adma.201804395 · Cited by 81
Zhang, B., Wan, S., Peng, X., Zhao, M., Li, S., Pu, Y., & He, B. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00327a · Cited by 78
Tang, X., Sheng, Q., Xu, C., Li, M., Rao, J., Wang, X., Long, Y., Tao, Y., He, X., Zhang, Z., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101083 · Cited by 73
Yuan, C.-S., Deng, Z., Qin, D., Mu, Y., Chen, X., & Liu, Y. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.030 · Cited by 72
Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment
Sameiyan, E., Bagheri, E., Dehghani, S., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.057 · Cited by 70
Ji, G., Ma, L., Yao, H., Ma, S., Si, X., Wang, Y., Bao, X., Ma, L., Chen, F., Ma, C., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.004 · Cited by 66
Wan, W., Qu, C., Zhou, Y., Zhang, L., Chen, M., Liu, Y., You, B., Li, F., Wang, D., & Zhang, X. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.06.030 · Cited by 65
Self-citationPeng, S., Wang, H., Zhao, W., Xin, Y., Liu, Y., Yu, X., Zhan, M., Shen, S., & Lu, L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202001832 · Cited by 65
Self-citationDandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation
Guo, Q., He, X., Li, C., He, Y., Peng, Y., Zhang, Y., Lü, Y., Chen, X., Zhang, Y., Chen, Q., et al. (2019) · Advanced Science · doi:10.1002/advs.201901430 · Cited by 63
Hypoxia-Responsive Polypeptide Nanoparticles Loaded with Doxorubicin for Breast Cancer Therapy
Zhang, P., Yang, H., Shen, W. H., Liu, W., Chen, L., & Xiao, C. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00125 · Cited by 63
ATP-Responsive Drug Delivery Systems
Sun, W., & Gu, Z. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1140147 · Cited by 62
Liang, L., Wen, L., Weng, Y., Song, J., Li, H., Zhang, Y., He, X., Zhao, W., Zhan, M., Li, Y., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.131451 · Cited by 62
Shin, J., Shum, P., Grey, J., Fujiwara, S., Malhotra, G. S., González-Bonet, A., Hyun, S., Moase, E. H., Allen, T. M., & Thompson, D. H. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300326z · Cited by 58
Zhang, Y., He, X., Zhang, Y., Zhao, Y., Lu, S., Peng, Y., Lu, L., Hu, X., & Zhan, M. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130171 · Cited by 58
Li, S., Bennett, Z. T., Sumer, B. D., & Gao, J. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00475 · Cited by 57
Wang, N., Zhou, Y., Xu, Y., Ren, X., Zhou, S., Shang, Q., Jiang, Y., & Luan, Y. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.125995 · Cited by 53
Stimuli‐Responsive Biomaterials for Vaccines and Immunotherapeutic Applications
Pacifici, N. J., Bolandparvaz, A., & Lewis, J. S. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000129 · Cited by 52
Peng, S., Men, Y., Xie, R., Tian, Y., & Yang, W. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.12.035 · Cited by 50
Self-citationTargeting hypoxia brings breath of fresh air to cancer therapy
Moyer, M. W. (2012) · Nature Medicine · doi:10.1038/nm0512-636b · Cited by 47
Deng, S., Iscaro, A., Zambito, G., Mijit, E., Minicucci, M., Essand, M., Löwik, C. W. G. M., Muthana, M., Censi, R., Mezzanotte, L., et al. (2021) · Nanomaterials · doi:10.3390/nano11010144 · Cited by 46
Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy
Li, Y., Zhang, X., Liu, X., Pan, W., Li, N., & Tang, B. (2021) · Chemical Science · doi:10.1039/d0sc06557a · Cited by 43
Chang, H., Zou, Z., Wang, Q., Li, J., Jin, H., Yin, Q.-X., & Xing, D. (2019) · Advanced Science · doi:10.1002/advs.201900069 · Cited by 42
Yin, J., Cao, H., Wang, H., Sun, K., Li, Y., & Zhang, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.004 · Cited by 42
Gao, J., Zhang, H., Zhou, F., Hou, B., Chen, M., Xie, Z., & Yu, H. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.12.009 · Cited by 41
Self-citationLiu, X., Feng, Y., Xu, G., Yang, C., Luo, Y., Song, J., Bao, Y., Yang, J., Yu, C., Li, Y., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201806916 · Cited by 40
pH‐Responsive STING‐Activating DNA Nanovaccines for Cancer Immunotherapy
Zhang, Y., Shen, T., Zhou, S., Wang, W., Lin, S., & Zhu, G. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000083 · Cited by 40
Peng, J., Xiao, Y., Yang, Q., Liu, Q., Chen, Y., Shi, K., Hao, Y., Han, R., & Qian, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.06.013 · Cited by 40
Liang, X., Li, X., Duan, J., Chen, Y., Wang, X., Pang, L., Kong, D., Song, B., Li, C., & Yang, J. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00890 · Cited by 39
Peng, S., Wang, H., Xin, Y., Zhao, W., Zhan, M., Li, J., Cai, R., & Lu, L. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101240 · Cited by 37
Self-citationKemp, A. J., Lyons, S. D., & Christopherson, R. I. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66800-0 · Cited by 35
Zhao, X., Liu, P., Song, Q., Gong, N., Yang, L., & Wu, W. D. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00600g · Cited by 34
Lv, M., Li, S., Zhao, H., Wang, K., Chen, Q., Guo, Z., Liu, Z., & Xue, W. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02334k · Cited by 33
Li, Y., Gong, S., Pan, W., Chen, Y., Liu, B., Li, N., & Tang, B. (2020) · Chemical Science · doi:10.1039/d0sc00293c · Cited by 31
Cited by
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Feng, C., Wang, Y., Xu, J., Zheng, Y., Zhou, W., Wang, Y., & Luo, C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121582 · Cited by 317
Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics
Wei, D., Sun, Y., Zhu, H., & Fu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.3c06019 · Cited by 303
Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy
Liu, P., Hao, L., Liu, M., & Hu, S. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1161472 · Cited by 58
Ultrasmall silica nanoparticles in translational biomedical research: Overview and outlook
Singh, N., Shi, S., & Goel, S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114638 · Cited by 35
Metadata
- Authors
- Peng, S., Xiao, F., Chen, M., & Gao, H.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2021-11-19
- Volume
- 9
- Issue
- 1
- Pages
- e2103836-e2103836
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W3213182963
- Cited by
- 441
- References
- 194
- FWCI
- 17.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.